Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism H3 receptor inverse agonists(Histamine H3 receptor inverse agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H31NO3S |
InChIKeyADRZQEOBUFIYAZ-LJQANCHMSA-N |
CAS Registry1021169-11-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Narcolepsy | Phase 1 | US | 01 Mar 2010 | |
Cataplexy | Phase 1 | - | - |